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Introduction
Lactic Acid Bacteria (LAB) isolated from aquatic environments 
produce a range of antagonistic molecules such as organic acids, 
hydrogen peroxide, diacetyl, and bacteriocins [1]. The characterization 
of these compounds supports the selection of beneficial LAB. Thus, 
some species have been proposed as probiotics to restore beneficial 
microbial populations that could help to control potentially pathogenic 
microorganisms in general aquaculture [2,3] and raniculture [4-6].
Probiotic products are generally designed with single or mixed 
beneficial bacterial strains, mainly LAB, but they could also include 
different bioactive compounds such as prebiotics (inulin) or 
bacteriocins [7]. Postbiotic metabolites (lactic and acetic acids and 
bacteriocins) produced by LAB strains have been extensively studied as 
feed additive to achieve high productivity and better laying hens’ health 
while reducing in-feed antibiotics [8].
Bacteriocins are ribosomally-synthesized antimicrobial peptides or 
proteins produced by different bacterial genera. They are usually active 
against genetically close species and have been grouped into four classes 
according to their genetic and biochemical characteristics and mode 
of action [9]. In recent years, bacteriocins have attracted increasing 
interest for their use as biopreservatives in food industry, Nisin and 
Pediocin PA, being commercially available as Nisaplin and ALTA 
2341, respectively. They are used as food additives [10] according to 
their GRAS (Generally Regarded as Safe) characteristics [11-13]. More 
recently, the effectiveness of Nisin A to reduce spoilage bacteria in 
high-fat chilled dairy dessert, a milk-based pudding, was reported [14].
Listeria is a ubiquitous bacterium extremely dangerous for high 
risk human populations. Listeria monocytogenes is the most pathogenic 
species associated with aquaculture products such as raw, smoked 
and fermented fish and crab meat [15,16]. It is a frequent inhabitant 
isolated from different frog species including the American bullfrog 
(Lithobates catesbeianus) [17] which meat is considered a delicacy in 
the international gastronomy. Thus, this pathogenic microorganism 
could be transferred as food-borne bacteria during bullfrogs’ meat 
manufacturing.
Enterocins are bacteriocins produced by Enterococcus species that 
are able to inhibit Gram-positives such as L. monocytogenes [18-23] 
and some Gram-negatives in a lesser degree [24-26].
In previous studies, we demonstrated that Gram-negative bacteria 
are responsible for Red-Leg Syndrome (RLS) outbreaks in raniculture: 
Also, enterococci were isolated from the autochthonous microbiota 
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Enterococcus gallinarum CRL 1826 isolated from an American bullfrog (Lithobates catesbeianus) skin inhibits 
the growth of Citrobacter freundii, Pseudomonas aeruginosa (bullfrog pathogens) and Listeria monocytogenes 
by a synergistic effect between organic acids and a bacteriocin-like molecule. This bacteriocin, named enterocin 
CRL 1826, showed a proteinaceous nature, heat stability and polar characteristics. Its production followed kinetics 
of primary metabolites synthesis reaching a maximum of 61,400 AU/mL. The minimum inhibitory and minimum 
bactericidal concentrations were 2,640 and 5,280 AU/mL, respectively, against L. monocytogenes. The addition 
of 120,000 AU/mL of enterocin to growing L. monocytogenes and Gram-negative (P. aeruginosa and C. freundii) 
bacteria showed bactericidal and bacteriostatic effects, respectively. However, enterocin derived-peptides had 
bactericidal effect only against Gram-negatives.
Enterocin produced cell envelope damages and efflux of citosolic content on L. monocytogenes, while enterocin 
derived-peptides showed granulation and contraction of cytoplasm material on P. aeruginosa and increase in the 
periplasmic space and empty cells appearance on C. freundii.
Enterocin CRL 1826 is the first bacteriocin described for E. gallinarum from raniculture. It could be used as a 
biopreservative while the derived-peptides represent an alternative to control multi-drug resistant Gram-negatives. 
The antimicrobial spectrum and the stability of enterocin and its derived-peptides indicate that they could be applied 
in different biotechnological areas.
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associated with L. catesbeianus hatchery environments [4,6,27]. 
Enterococcus gallinarum CRL 1826 isolated from the bullfrog skin 
inhibited the growth of L. monocygenes Scott A by a synergistic effect 
among lactic acid, hydrogen peroxide and a bacteriocin-like metabolite 
[6]. Preliminary studies have indicated that bacteriocin containing 
culture supernatants treated with proteolytic enzymes inhibited 
the growth of RLS-related pathogens (Pseudomonas aeruginosa 
and Citrobacter freundii). Taking into account that enteroccoci are 
considered no GRAS species [28,29], E. gallinarum CRL 1826 cannot 
be included in probiotics for raniculture. However, the natural 
products (bacteriocin/s) could be used as biopreservative to reduce L. 
monocytogenes prevalence or as a bioactive ingredient for probiotics 
formulation. 
Thus, the present study aimed to characterize the bacteriocin 
from E. gallinarum CRL 1826 culture supernatants and to evaluate its 
mode of action against a food-borne bacterium (L. monocytogenes) 
and indigenous RLS-related pathogens, as a potential bioactive agent 
to be included as biopreservative during the manufacture of bullfrog 
carcasses and probiotics’ formulation, respectively.
Materials and Methods
Bacterial strains and culture conditions
Enterococcus gallinarum CRL 1826 was isolated from the ventral 
skin of healthy L. catesbeianus and identified by phenotypic and 
genotypic tests [6]. The strain was grown on MRS broth [30], LAPT g 
broth [31] pH 6.8 and Brain Heart Infusion (BHI) broth pH 7.4, for 10 
h at 37°C in a 5% CO2-enriched chamber (microaerophilic conditions).
Pseudomonas aeruginosa 1047 and Citrobacter freundii CFb isolated 
from raniculture were grown in nutritive broth (in g/L: pluripeptone, 
5; meat extract, 3), pH 6.9 for 7 h while Listeria monocytogenes Scott 
A was cultured in BHI broth, for 6 h. All cultures were incubated at 
37°C in microaerophilic conditions [6,32]. Bacterial strains were stored 
at -20°C in their specific growth media supplemented with 20% (w/v) 
glycerol.
Characterization of the bacteriocin produced by Enterococcus 
gallinarum CRL 1826
One-hundred milliliters of 10 h cultures of E. gallinarum CRL 1826 
grown in MRS, LAPTg and BHI broth were centrifuged (3,000 g at 4°C, 
20 min) and 3 mL fractions of crude (untreated), neutralized (NS) and 
neutralized+catalase (treated) supernatants were used to determine 
the chemical nature of the bacteriocin-like metabolite. Its activity was 
evaluated by the agar-well diffusion assay according to Pasteris et al. 
[4]. Thus, soft BHI agar (0.7% w/v) plates were inoculated with 1 × 
105 CFU/mL L. monocytogenes. Then, 100 µL of untreated, NS, and 
treated supernatants were added to the plates in which 10 mm holes 
had been previously punched. Fractions of crude supernatants were 
formerly adjusted to pH 7.0 with 1 N NaOH (NS) and NS samples were 
supplemented with 0.5 mg/mL catalase (1 h at 25°C) to abolish the 
inhibitory effect due to organic acids and H2O2, respectively [4].
The antimicrobial titer was defined as the reciprocal of the highest 
two fold dilution able to produce a clear zone of inhibition and was 
expressed as arbitrary units per milliliter of culture supernatant (AU/mL).
Chemical nature of the bacteriocin
Two-milliliter fractions of treated supernatants from MRS cultures 
were supplemented with 1 mg/mL pepsin, α-chymotrypsin, trypsin, 
lipase and α-amylase. Enzymes were suspended in their specific buffer 
solutions according to the suppliers’ indications [32]. Positive and 
negative controls were performed with enzyme solutions and treated 
fractions diluted with sterile water, respectively. Enzymatic treatments 
of cell-free supernatants were carried out for 1 h at 37°C except for 
α-chymotrypsin that were incubated for 1 h at 25°C [32]. 
Physicochemical characterization of the bacteriocin produced 
by the lactic acid bacterium
Effect of organic solvents and filtration on bacteriocin activity: 
Five-milliliter fractions of untreated and treated supernatant were 
supplemented with different organic solvents: 10 and 20% (v/v) 
hexadecane, ethyl acetate, chloroform and ethanol [4,5].
Moreover, 2-mL fractions of untreated and treated supernatants 
were filtered throughout 0.22 µm Millipore membranes (Sigma-
Aldrich). The collected untreated samples were neutralized with 1 N 
NaOH before the quantification of bactericion activity [32]. 
Temperature stability of the bacteriocin: Five-milliliter fractions 
of untreated and treated supernatants were exposed to 60, 80 and 100°C 
for 10, 20 and 30 min and to 121°C (autoclave) for 1, 5, 10, 15 and 30 
min previous to residual bacteriocin activity determination. Samples 
without treatment were used as control.
Growth of Enterococcus gallinarum CRL 1826 and kinetics of 
the bacteriocin production
Growth of the LAB strain was evaluated in MRS broth for 34 h in the 
conditions stated above. Samples were taken at different time intervals 
for growth determinations [optical density λ= 540 nm and number of 
colony-forming units (CFU/mL)]. Cultures were centrifuged (3,000 
g at 4°C, 15 min) to obtain crude supernatants which were used for 
pH determinations [4-6]. Treated supernatants were then used for 
bacteriocin quantification against L. monocytogenes [32].
Storage conditions: effect of pH and temperature on 
bacteriocin stability
To study the stability of the bacteriocin during storage, untreated 
and treated cell-free supernatants fractions were kept at -20°C and the 
residual bacteriocin activity was determined up to 42 days.
The combined effect of pH and temperature on the bacteriocin 
stability during storage was evaluated. Thus, 30-mL fractions of the 
LAB strain supernatants containing bacteriocin were heated at 80°C for 
30 min adjusted to pH values between 2 and 9 by using sterilized 1 N 
HCl and NaOH solutions and kept at 4 and 25°C for 7 days. Every day 
samples were removed, neutralized and treated with catalase previous 
to bacteriocin quantification [32].
Minimum inhibitory concentration (MIC) and minimum 
bactericidal concentration (MBC) of the bacteriocin
Culture supernatants of E. gallinarum CRL 1826 were obtained 
according to the protocol described above, concentrated 10 times in a 
SAVANT (SpeedVac® Concentrators), and filtered throughout 0.22 µm 
Millipore membranes. Sterilized supernatants were adjusted to pH 7.0 
with 5 N NaOH and the bacteriocin quantification was carried out by 
using L. monocytogenes as indicator strain [32].
The MIC of the bacteriocin was determined by the method of 
dilution in BHI broth following the guidelines of the Clinical Laboratory 
Standard Institute (CLSI) [33], while the MBC was determined 
according to the CLSI [34] recommendations.
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Mode of action of the bacteriocin on pathogen cells
The effect of the bacteriocin on indigenous RLS-related pathogens 
(C. freundii and P. aeruginosa) and L. monocytogenes was evaluated 
following the guidelines of the CLSI [34]. Thus, 200-mL LAB cultures 
(6 h at 37°C) were harvested; cells were washed twice with sterile 
Phosphate-Buffered Saline (PBS, pH 7.0) and suspended in order to 
get approximately 1 × 108 CFU/mL. Concentrated supernatants were 
obtained as indicated above and 4.75 mL of a-treated supernatant and 
b-treated supernatant + trypsin were supplemented with 0.2 mL BHI 
broth to reach the nutritional conditions suitable for pathogens growth 
and then inoculated with the pathogen cell suspensions to obtain 5 
× 106 CFU/mL. The bacteriocin concentration in each treatment was 
120,000 AU/mL.
Treated supernatant + trypsin were heated at 121°C for 10 min to 
abolish the enzyme activity on bacterial cell wall components.
All the samples were incubated at 37°C in microaerophilic 
conditions and the number of viable cells (CFU/mL) was determined 
every hour during 6 h. The ultrastructural cell damages were analyzed 
in L. monocytogenes cells treated with bacteriocin for 30 min and on 
RLS-related pathogens treated with bacteriocin derived-peptide: 1.5 h 
for P. aeruginosa and 2.5 h for C. freundii.
Transmission electron microscopy (TEM)
Pathogenic cells obtained under each of the experimental 
conditions described above were harvested, suspended in MRS 
medium supplemented with 3% glutaraldehyde (1:1 v/v) and incubated 
for 30 min at room temperature; then they were centrifuged at 3,000 
g at 4°C for 5 min and suspended in 3% glutaraldehyde. Finally, cells 
were processed and observed by TEM [35].
Chemicals, Millipore membranes and enzymes used were 
purchased from Sigma-Aldrich Chemical Co., St. Louis, MO (USA). 
The components for LAPTg preparation were supplied by Britania 
laboratories (Buenos Aires, Argentina) while MRS and BHI media 
were obtained from Merck (Germany).
Statistical analysis
The results correspond to the media of three independent assays. 
Statistical treatments were performed using INFOSTAT software 
(2008 student version). For bacteriocin thermal sensitivity assays, one-
way analysis of variance (ANOVA) was applied to the experimental 
data by using Student’s t-test for multiple mean comparisons (95% 
confidence interval). The significant differences among the residual 
bacteriocin activity under storage conditions were determined by 
applying the non-parametric analysis of variance (Kruskal Wallis test, 
95% confidence interval).
Results
Chemical nature and thermal stability of the bacteriocin 
produced by Enterococcus gallinarum CRL 1826
The antimicrobial activity of treated (neutralized + catalase) 
supernatants from the E. gallinarum strain cultures was abolished when 
fractions were subjected to the action of pepsine, chymotripsin and 
trypsin, indicating that the inhibitory metabolite has a proteinaceus 
nature. Amylase and lipase did not affect the bacteriocin activity (Table 
1). Thus, the bacteriocin was named enterocin CRL 1826. The LAB 
strain was able to produce enterocin in all the media assayed in this 
work: MRS, LAPTg and BHI broth. The highest inhibitory activity 
values were detected in MRS (data no shown), then, samples from 
MRS cultures were used for the bacteriocin characterization. Therefore, 
the effect of some physicochemical factors on enterocin stability was 
evaluated. No differences in the activity were detected when organic 
solvents were added to both untreated and treated culture supernatants. 
Their supplementation with 10 and 20% (v/v) hexadecane did not 
modify the bacteriocin activity, while the addition of 10 and 20% (v/v) 
ethyl acetate decreased it by 25%; and 10 and 20% (v/v) chloroform 
by 45 and 69%, respectively. Also, ethanol inhibited the enterocin 
activity by 78% (Table 1). Filtration did not affect enterocin activity, 
independently of the supernatant fraction evaluated.
The effect of heating on enterocin CRL 1826 stability was 
determined and no significant differences (P>0.05) between treated and 
untreated supernatants were observed (Figure 1A). The antimicrobial 
molecule was stable up to 80°C for 30 min as its residual activity did 
not differ significantly from the control (P>0.05). At 100°C a significant 
diminution (59 ± 13%) in the inhibitory activity was observed 
(Figure 1B). Moreover, at 121°C the loss of the enterocin activity was 
significantly affected (P≤0.05) and depended on pH values. After 15 
min treatment, 50 and 20% residual activity were detected in untreated 
and treated supernatants, respectively (Figure 1B).
Growth and kinetics of the enterocin production by 
Enterococcus gallinarum CRL 1826
The growth of E. gallinarum CRL 1826 in MRS broth under 
microaerophilic conditions and the enterocin production using L. 
monocytogenes as indicator strain are shown in Figure 2. After 4 h, the 
LAB strain grew exponentially during 6 h, while the number of viable 
cells increased 2.5 log10 units and the pH decreased about 1.0 unit at 
10 h culture. The enterocin synthesis started at the beginning of the 
exponential growth phase (40 AU/mL), reaching a maximum of 61,440 
AU/mL at the end of this phase (6 h). Then, enterocin activity remained 
stable until 16 h culture; however, at 22 h it diminished up to 25,600 
AU/mL, title that was kept until the end of the assay (34 h) (Figure 2).
Effect of pH and temperature of storage on enterocin stability
No inactivation of the enterocin CRL 1826 was observed when 
untreated and treated supernatants of the LAB strain were stored at 
-20°C for 42 days (data not shown).
When crude supernatants were adjusted to pH between 2 and 9 
and stored at 4 and 25°C for 7 days, the pH did not exert significant 
effect (P>0.05) on the residual enterocin activity (Figure 3A). On the 
other hand, a significant decrease (P≤0.05) in bacteriocin activity was 
observed during the storage of untreated and treated supernatants, 
Supernatant Residual activity (%)*
Neutralized + catalase (N+C) 100**
N+C + pepsin 0
N+C + trypsin 0
N+C + α-chymotrypsin 0
N+C + lipase 100
N+C + α-amylase 100
10 and 20% hexadecane 100
10 and 20% ethyl acetate 75
10% chloroform 55
20% chloroform 31
10 and 20% ethanol 22
Table 1: Effect of chemical treatments on bacteriocin activity; *Percentage of the 
inhibitory activity on L. monocytogenes growth; **100%=61,440 AU/mL (control).
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MIC, MBC, mode of action of the enterocin on pathogenic 
bacteria and studies of cell damage
The MIC of enterocin CRL 1826 against L. monocytogenes was 
2,640 AU/mL while the MBC resulted in 5,280 AU/mL. The effect of the 
addition of 120,000 AU/mL enterocin on L. monocytogenes, C. freundii 
and P. aeruginosa cells was studied. Therefore, neutralized supernatants 
exerted a bactericidal effect on L. monocytogenes and no viable cells 
were detected at 60 min co-incubation (Figure 4). However, when 
samples of treated supernatants were supplemented with trypsin before 
its addition to pathogenic cells, a bacteriostatic effect was observed. 
The same effect was also detected for C. freundii and P. aeruginosa 
when cells were co-incubated with neutralized supernatants (data not 
shown). When these supernatants were then treated with trypsin, a 
bactericidal effect was observed and no cell counts were detected at 2 
and 3 h incubation for P. aeruginosa and C. freundii, respectively. 
When analyzing the control samples, L. monocytogenes grew 
poorly (0.22 log units) while P. aeruginosa and and C. freundii grew to 
0.46 and 0.59 log units, respectively.
Ultrastructural studies in L. monocytogenes cells treated with 
bacteriocin and both P. aeruginosa and C. freundii treated with 
bacteriocin derived-peptides were performed. Listeria revealed that the 
predominant features of morphological alterations concern the partial 
indicated by the factor time according to the Kruskal Wallis analysis 
(Figure 3A). 
Although the statistical analysis of the data did not show significant 
differences between both temperatures of storage, a dissimilar profile 
in the mean values of the residual enterocin activity was observed when 
supernatants were stored at 4 and 25°C (Figure 3B and 3C). Therefore, 
at 4°C the highest enterocin activity was detected at pH 4 and 5, while 
at 25°C the highest activity was obtained when supernatants were 
stored at neutral pH (6.5 ± 0.5).
a)
b)
Figure 1: Effect of temperature and time on enterocin CRL 1826 activity (a) 60, 80 and 100°C for 10, 20 and 30 min (b) 121°C  for 1, 5, 10, 15 and 30 min. Results are 
expressed as % of residual activity (100% = 61,440 AU/mL). Black bars: crude supernatants; gray bars: neutralized supernatants.
Figure 2: Growth and bacteriocin production by Enterococcus gallinarum 
CRL 1826
Log CFU/mL  AU/mL  O.D.  pH 
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dissolution of the cell content (diminution in the cytosolic electron 
density) and damage of the cell envelope which enabled an efflux of cell 
material (Figure 5A and 5B). Pseudomonas showed both granulation 
and contraction of cytoplasm material (Figure 5C and 5D) while 
Citrobacter showed an increase in the periplasmic space and empty 
cells appearance (Figure 5E and 5F).
Discussion
Enterocins are antimicrobial substances with a potential use as 
biopreservatives in food, feed, and also as alternative therapies instead 
of antibiotics for human and animals [36]. Some enterocins were 
reported to be active against L. monocytogenes and their potential 
antilisterial activity was also shown in a murine model of pregnancy-
associated listeriosis [37]. Moreover, few enterocins have been found to 
be effective against Gram-negatives, an unusual characteristic among 
bacteriocins from LAB species [24,25].
E. gallinarum CRL 1826 is an autochthonous LAB strain isolated 
from bullfrog skin in hatchery conditions [6]. The synergistic effect 
of a bacteriocin-like molecule, hydrogen peroxide and organic acids 
against L. monocytogenes Scott A was previously demonstrated [6] and 
preliminary studies showed that bacteriocin derived-peptides were 
effective against C. freundii and P. aeruginosa (RLS-related pathogens 
for raniculture). On the basis of these observations, the aim of this work 
was to go further on the characterization of the bacteriocin produced 
by E. gallinarum CRL 1826 from cell-free supernatants, supported by 
their potential biotechnological applications. The results indicate that 
the inhibitory molecule has a proteinaceus nature and therefore it was 
named enterocin CRL 1826.
Most of the enterocins have been reported to be produced 
by E. faecium and E. faecalis strains [26,38,39], although some 
bacteriocinogenic E. mundtii [40-42], E. casseliflavus [43], E. hirae 
[44], E. avium [45] and E. durans [23] strains were described. With 
respect to E. gallinarum strains, Jennes et al. [46] characterized for the 
first time the enterocin 012 produced by E. gallinarum 012 isolated 
from the intestinal tract of ostrich. To our knowledge, there are no 
reports on bacteriocins produced by this LAB species isolated from 
Figure 3: Main effects of pH, temperature and time on enterocin CRL 1826 stability during storage (a) Global position; (b) 4°C; (c) 25°C. Similar letters indicates no 
significant differences (P≤0.05) by using Kruskal Wallis test between initial and final points.
Figure 4: Growth inhibition of pathogenic bacteria by both enterocin and 
enterocin-derived peptides fractions
L. monocytogenes control ( ) and neutralized supernatant + catalase 
( )
P. aeruginosa control ( ) and  neutralized supernatant + catalase + 
tripsine ( )
C. freundii control ( ) and  neutralized supernatant + catalase + tripsine 
( )
Samples containing enzymes were treated at 121°C, 3 min before dead 
curves performance.
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aquaculture-related activities, thus enterocin CRL 1826 represents the 
first bacteriocin produced by E. gallinarum CRL 1826 isolated from 
captive bullfrogs.
Enterocin CRL 1826 inhibited the growth of Lactobacillus 
plantarum, Pediococcus pentosaceus, Lactococcus lactis and L. garvieae 
strains isolated from a bullfrog hatchery (data no shown) as well as 
L. monocytogenes Scott A. Overall, bacteriocins produced by LAB are 
effective against closely related Gram-positives species [9] and most of 
the enterocins are able to inhibit the Listeria species growth since they 
are phylogenetically associated with the genus Enterococcus. However, 
enterocin´s inhibition on P. aeruginosa, P. putida, Salmonella spp., 
Salmonella Typhimurium, Escherichia coli, Acinetobacter baumanii, 
Klebsiella pneumoniae, Proteus spp., P. mirabilis, Citrobacter spp., 
Enterobacter spp., Vibrio spp., Shigella spp., was also reported [26,46-50].
Enterocin CRL 1826 showed kinetics of primary metabolites 
synthesis since its production started at the beginning of the log 
growth phase, reaching a maximum of 61,400 AU/mL at the end of 
this phase. Then, the bacteriocin activity decreased. This diminution 
can be attributed to the presence of proteolytic enzymes in the culture 
supernatants or to the low pH values that allows the bacteriocin to be 
absorbed to the bacterial wall cell [51]. Similar results were reported 
for the enterocins produced by E. mundtii [42] and E. faecium [52,53]. 
Figure 5: Transmission electronic microscopy of pathogens incubated with enterocin and enterocin-derived peptides fractions. L. monocytogenes treatment: A- 
22,800X, B- 56,600X, control: G- 22,800X. P. aeruginosa treatment: C- 22,800X, D- 56,600X, control: H- 22,800X. C. freundii treatment: E- 22,800X, F- 56,600X, 
control: I- 22,800X. IM: Internal Membrane; EM: External Membrane; WC: Wall Cell; PS: Periplasmic Space; CD: Cellular Disruption. *Diminution of electron density. 
Scale bar: 200 nm.
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However, Jennes et al. [46] reported a different behavior for the 
enterocin 012 synthesis that started in the middle log phase, reaching 
a first maximum at the end of this phase and a second one with the 
highest enterocin activity during the stationary growth phase.
Enterocin CRL 1826 was heat stable and polar. Its inhibitory 
activity was preserved in a pH range between 2 and 9 for 48 h and was 
not affected when stored for 42 days at -20°C. These properties were 
reported for mundticin KS [40] and enterocin QU2 [41] produced by 
E. mundtii, and the bacteriocins produced by E. faecium JCM 5804T 
[54] and GM-1 [48]. Therefore, enterocin CRL 1826 could be classified 
into Class II bacteriocins: heat stable peptides with antilisteria activity 
[10]. 
The MIC and MBC of enterocin CRL 1826 were 2,640 and 5,280 
AU/mL, respectively by using L. monocytogenes and the addition 
of 120,000 AU/mL enterocin CRL 1826 on food-borne growing 
cells showed bactericidal effect which was switched to bacteriostatic 
when enterocin-containing supernatants were previously treated 
with trypsin. However, the released-peptides from enterocin showed 
bactericidal effect on Gram-negatives from raniculture which must 
be identified once enterocin CRL 1826 is purified. Saavedra et al. 
[55] reported that derived-peptides from the C-terminal domain 
diminished the enterocin CRL 35 activity; while those from middle 
N-terminal domain improved it when used combined. However, 
none of them showed activity individually. Later, Salvucci et al. [37] 
demonstrated the inhibitory activity of N-terminal released peptides 
from mesentericin Y105, pediocin PA-1, sakasin P, piscicolin 126 and 
listeriocin 743A.
Enterocin produced cell envelope damages and efflux of 
cell material on L. monocytogenes. This effect was reported by 
purified enterocin E1A, a bacteriocin produced by Streptococcus faecium 
E1 on a L. monocytogenes strain [56]. With respect to enterocin-derived 
peptides, they produced granulation and contraction of cytoplasm 
material on P. aeruginosa and increase in the periplasmic space and 
empty cells appearance on C. freundii. It represents the first report 
regarding the mode of action of bacteriocin derived-peptides on Gram 
negatives, since it has only been previously reported for plantaricin 
MG on Salmonella Typhimurium [57], EDTA plus bacteriocin-like 
substance produced by Bacillus sp. P34 on Escherichia coli and S. 
Typhimurium [58] and lipase plus enterocin on other E. coli and S. 
Typhimurium strains [59]. 
Listeriosis is one the main diseases associated with industrial 
food processing; therefore it is placed in the high social and economic 
relevance diseases [60]. L. monocytogenes is a normal inhabitant of 
amphibian species including L. catesbeianus [17], thus bullfrog legs 
may not meet appropriate microbiological standards by virtue of 
methods of collection and preparation, and then cross-contaminations 
are of main concern. These products are intended for the direct use 
of the final consumer; therefore decontamination with enterocin CRL 
1826 would increase meat safety. 
To maintain the organoleptic characteristics and nutritional 
properties of food during conservation, the use of bacteriocinogenic 
LAB strains offers potential alternative applications to diminish the 
utilization of chemicals preservatives and intensity of heat treatments. 
Therefore, Nisaplin and Alta 2341 are used as food additives [10].
Taken into account that E. gallinarum CRL 1826 is not appropriated 
to be included in a multi-strain probitiotic for raniculture, enterocin 
CRL 1826 would represent an interesting bioactive compound to be 
combined with probiotics to control/prevent the RLS outbreaks. The use 
of nisin in aquaculture products has been reported to control botulism 
in fish vacuum packed and L. monocytogenes in smoked salmon and 
crab meat [61]. Bacteriocins can be added as concentrated preparations 
to preserve food, as additives or ingredients to extend the shelf life, or 
they can be produced in situ by starters, adjunct or protective cultures 
[62]. Therefore, enterocin CRL 1826 would be used as a biopreservative 
since it was stable in a range of pH and temperatures and able to inhibit 
L. monocytogenes after 1 h co-incubation.
Finally, the enterocin derived-peptide represents veterinary/
pharmaceutical alternatives to control multidrug-resistant Gram-
negatives such as P. aeruginosa and C. freundii [63]. 
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